SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Amgen Inc. on Thursday reported third-quarter financial results that exceeded Wall Street’s expectations.
Shareholders of St. Jude Medical Inc. on Wednesday approved the $25 billion deal for pharmaceutical giant Abbott will acquire the medical device maker, which has a manufacturing plant in Sylmar.
Hixme Insurance Solutions Inc. announced Wednesday that it has raised $14.1 million in a Series B funding.
Second Sight Medical Products Inc. on Tuesday announced the first successful human implantation of a wireless visual cortical stimulator – a big step in the ongoing development of its Orion I Visual Cortical Prosthesis.
Amgen Inc. on Friday announced that the company has appointed Ellen Kullman to its board of directors, expanding it from 13 to 14 members.
Biotech company Akriveia Therapeutics has received a $7.5 million Series A investment from an East Coast venture capital firm.
Henry Mayo Newhall Hospital in Valencia has named a new chief medical officer and vice president of professional services, the hospital announced Wednesday.
St. Jude Medical Inc. has alerted patients and doctors that some of its implanted heart devices have battery defects that may cause premature power loss.
Los Angeles real estate brokerage CBRE Inc. has arranged the sale of a $1.15 billion portfolio that includes several Valley health care properties.
Health management company Apollo Medical Holdings Inc. announced Monday that its affiliate medical group ApolloMed Hospitalists has been contracted to provide its services to Lompoc Valley Medical Center.
Avita Medical Ltd. is opening a dedicated clinic for its regenerative skin treatments in Iran, the company announced Wednesday.
About 1,000 nurses at Antelope Valley Hospital on Thursday ended their 24-hour strike, which was the first of its kind in the hospital’s 61-year history.
An assisted living and memory care facility has received more than $16 million in financing to break ground this month in Thousand Oaks.
MannKind Corp. on Friday announced that it has received a delisting notice from the Nasdaq stock exchange, as the company has traded below $1 for more than 30 days.
Amgen Inc.’s biosimilar to top-selling drug Humira was approved Friday by the U.S. Food and Drug Administration.